Table 3.
ISOLATES | SOURCE | BA | CL | CH | PR | TE | CP | AK | AS | SC | OF | NX | LE |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E. coli | SCD | S | S | R | S | S | S | S | R | S | S | S | S |
E. coli | SCD | S | S | R | R | R | S | S | R | S | S | S | S |
E. coli | SCD | R | S | S | S | R | S | S | R | S | S | S | S |
E. coli | SCD | S | R | S | R | R | R | S | R | S | S | S | S |
E. coli | NSCD | S | S | S | S | R | S | S | R | S | S | S | S |
E. coli | NSCD | R | R | R | R | R | S | S | R | S | R | S | R |
CNS | NSCD | R | S | S | S | S | S | S | S | S | S | S | S |
CNS | NSCD | R | R | R | S | S | S | S | R | S | S | S | S |
CNS | NSCD | R | I | R | S | S | S | S | R | S | S | S | S |
CNS | NSCD | S | R | R | S | R | S | S | R | S | S | S | S |
CNS | NSCD | R | S | S | S | R | S | S | R | S | S | S | S |
CNS | SCD | R | R | S | S | R | R | S | S | I | S | S | S |
CNS | SCD | S | S | S | S | S | S | S | S | S | S | S | S |
CNS | SCD | S | R | S | R | R | S | I | R | S | S | S | S |
CNS | SCD | S | S | R | S | S | S | S | R | S | S | S | S |
K. oxytoca | SCD | R | S | R | R | R | S | S | R | S | S | S | S |
S. aureus | NSCD | S | S | S | S | S | S | S | R | S | S | S | S |
S. aureus | SCD | S | S | S | S | S | S | S | R | S | S | S | S |
Enterobacter sp. | SCD | S | S | R | S | S | S | S | S | S | S | S | S |
Enterobacter sp. | SCD | S | S | R | R | R | S | S | R | S | S | S | S |
Enterobacter sp. | SCD | R | S | R | S | S | S | S | R | S | S | S | S |
Citrobacter sp. | SCD | R | R | S | R | R | S | R | R | S | S | S | S |
S. aureus—Staphylococcus aureus; K. oxytoca—Klebsiella oxytoca; CNS—coagulase-negative Staphylococcus sp.; E. coli—Escherichia coli; SCD—sickle cell disease; NSCD—non-sickle cell disease; R—resistant; S—susceptible; I—intermediate; BA—cotrimoxazole; AK—amikacin; CL—ceftizoxime; AS—ampicillin; CH—chloramphenicol; SC—sparfloxacin; PR—cephalexin; OF—ofloxacin; TE—tetracycline; NX—norfloxacin; CP—ciprofloxacin; LE—levofloxacin.